newsfilter
← Latest News
GlobeNewswire·

Entrada Therapeutics Announces $100 Million Registered Direct Offering

BOSTON, June 24, 2024 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (NASDAQ:TRDA) is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that